- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05137691
Health After Birth Intervention Trial (HABIT)
A Feasibility RCT Investigating the Effect of a Kilocalorie Controlled, Low Carbohydrate Dietary Intervention, Behavioural Modification and Telehealth vs a Standard 1:1 NHS Weight Management Programme in Post-partum Women Living With Obesity
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
For individuals living with obesity, the post-partum period is currently the initial, optimal timeframe for weight management. Many women reconceive during the post-partum phase, increasing the risk of between-pregnancy bodyweight retention and even gain. Consequentially, many re-enter subsequent pregnancies with a higher BMI often associated with unfavourable obstetric outcome and further cyclical perpetuation.
Health behaviour change is an important facet within weight management interventions and delivery may be enhanced by digital technologies, for example, telehealth. Short messaging service (SMS) may be used to enhance communication between patients and practitioner and is relatively inexpensive to use.
Low carbohydrate diets continue to gain traction however research is arguably confounded by the lack of a universally agreed definition and classification. Feinman and colleagues (2015) propose intermediary categories. The experimental arm of this trial will be encouraged to adopt a non-ketogenic LCD as per Feinman.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Edinburgh, United Kingdom, EH9 2HL
- Astley Ainslie Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult aged 18 or above
- Ready and motivated to make lifestyle changes
- Have a Body Mass Index of ≥30 kg/m2 (at initial booking appointment)
Additional study specific criteria
- English speaking and ability to read English language
- Capacity to consent to participating in the study
- Are non-diabetic or those with Type 2 diabetes which is diet controlled
- Deemed medically fit by GP/medical professional to participate via email
- Have recently given birth (within 1 year)
- Are not receiving weight management support elsewhere e.g. NHS, Scottish slimmers, weight watchers
- Have access to a mobile phone and weighing scales
Exclusion Criteria:
- Have uncontrolled hypothyroidism
- Have unstable psychosis or severe and unstable personality disorder
- Are pregnant
- Have dementia
- Have moderate to severe learning disability or learning difficulty which impairs the ability to adhere to the programme (identified by medical history and confirmed with GP)
- Current alcohol or substance misuse (6 month period of abstinence)
- Active purging
- Bulimia Nervosa
- Binge Eating Disorder
Additional study specific criteria
- Known cancers
- Type 1 Diabetes or Type 2 Diabetes on any Diabetic medication (including Insulin)
- Have a pacemaker
- Renal impairment
- Taking Orlistat or any other weight loss medication or had previous bariatric surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
Adapted NHS weight management 1:1 programme.
Low carbohydrate dietary focus, enhanced behaviour change via telehealth, daily step target supported by pedometers
|
Adapted NHS 1:1 weight management programme with a low carbohydrate dietary focus, incorporating enhanced behaviour change via telehealth, step count and pedometer
|
|
Active Comparator: Active comparator NHS 1:1 weight management programme
12 week NHS 1:1 weight management programme
|
NHS 1:1 weight management programme
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Bodyweight (Kilograms)
Time Frame: Proposed 0,3,6,8 months
|
Bodyweight measured by the CI or self-reported
|
Proposed 0,3,6,8 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Body composition (Fat mass/fat free mass)
Time Frame: Proposed 0,3,6,8 months
|
Medical grade
|
Proposed 0,3,6,8 months
|
|
Change in Waist circumference (Centimetres)
Time Frame: Proposed 0,3,6,8 months
|
SECA Ergonomic measuring tape
|
Proposed 0,3,6,8 months
|
|
Change in systolic and diastolic Blood pressure
Time Frame: Proposed 0,3,6,8 months
|
Standard technique
|
Proposed 0,3,6,8 months
|
|
Change in Physical activity levels
Time Frame: Proposed 0,3,6,8 months
|
Level of physical activity (minutes) and step count from pedometer data
|
Proposed 0,3,6,8 months
|
|
Change in emotional eating using the Weight loss Readiness Test II
Time Frame: 0,3,6,8 months
|
Incidence of emotional eating (if present) determined by change score.
Increased score is less favourable
|
0,3,6,8 months
|
|
Change in hunger and eating cues using the Weight loss Readiness Test II
Time Frame: 0,3,6,8 months
|
Hunger and eating cues determined by change score.
Increased score is less favourable
|
0,3,6,8 months
|
|
Change in psychological distress (if present) using the Clinical Outcomes in Routine Evaluation-10 screening tool
Time Frame: Baseline, post-intervention at 3 months
|
Measured using the Clinical Outcomes in Routine Evaluation-10 tool using change scores.
An increased score is less favourable
|
Baseline, post-intervention at 3 months
|
|
Change in Quality of life
Time Frame: Proposed 0,3,6,8 months
|
Measured using the World Health Organisation Quality of life (BREF) tool.
A lower score is less favourable
|
Proposed 0,3,6,8 months
|
|
Food frequency questionnaire
Time Frame: Baseline
|
Standard validated tool
|
Baseline
|
|
Diet quality
Time Frame: Proposed 0,3,6,8 months
|
Diet quality measured using a 3 day unweighed food diary
|
Proposed 0,3,6,8 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ashleigh Graham, Queen Margaret University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10052021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Adapted NHS weight management 1:1 programme
-
London South Bank UniversityNHS Lambeth; NHS Southwark CCG; Allen Carr EasywayCompleted
-
University of PlymouthNational Institute for Health Research, United KingdomNot yet recruitingQuality of Life | Weight Loss | Health Economics
-
National Healthcare Group PolyclinicsKhoo Teck Puat HospitalRecruitingObesity | Diabetes Mellitus, Type 2Singapore
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonEnrolling by invitationObesity | Obesity & OverweightUnited Kingdom
-
Revmatismesykehuset ASSouth-Eastern Norway Regional Health AuthorityCompletedMusculoskeletal Diseases or ConditionsNorway
-
Hacettepe UniversityCompleted
-
Zekai Tahir Burak Women's Health Research and Education...Completed
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaNot yet recruiting
-
Talita Cumi Ltd.Not yet recruiting
-
Noom Inc.CompletedObesity | Weight Loss | Overweight and Obesity | Self Efficacy | Behavior, Health | Behavior, EatingUnited States